REFERENCES
1. Furst DE, Ulrich RW, Varkey-Altamirano C. Nonsteroidal Anti-Inflammatory Drugs, Disease Modifying Antirheumatic Drugs, Nonopioids Analgesics, & Drugs Used in Gout. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. Page: 626.
2. Grosser T, Smyth E, FitzGerald GA. Anti-Inflammatory, Antipyretic, and Analgesic Agents; Pharmacotherapy of Gout. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. Page: 986-987.
3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page:295-297.
4. Julie Pradal, Coralie M Vallet, Guillaume Frappin, Frédérique Bariguian and Maria Stella Lombardi. Importance of the formulation in the skin delivery of topical diclofenac: not all topical diclofenac formulations are the same: Journal of pain research. April 12, 2012; [Accessed on Jan 20, 2021] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489664/
5. Amdeepcha Limited, Laboratórios Basi – Indústria Farmacêutica, S.A. Electronic Medicines Compendium (EMC); [Revised on Jan, 2020] [Accessed on Jan 20, 2021] https://www.medicines.org.uk/emc/files/pil.10950.pdf
6. GlaxoSmithKline Consumer Healthcare (UK). Electronic Medicines Compendium (EMC); [Revised on March, 2020] [Accessed on Jan 21, 2021] https://www.medicines.org.uk/emc/files/pil.366.pdf